Glutathione

Glutathione is a tripeptide built from glycine, cysteine and glutamic acid, and it is the most plentiful antioxidant inside human cells. Almost every cell makes its own, with concentrations highest in the liver, where it sits at the center of clearing drugs, environmental toxins and metabolic waste. It also supports immune cells and regenerates other antioxidants, vitamins C and E among them.

Levels fall with age, with chronic illness, with heavy drinking and with sustained oxidative stress. Wellness clinics offer it three ways — infused, injected into muscle, or swallowed — promising antioxidant support, lighter skin, a healthier liver and better immunity. Of those, skin lightening has the most published human trial data behind it — from trials that are small, and effects that are modest.

Framed honestly, the split is this: that the body needs glutathione is not in question. Whether supplementing it, orally above all, lifts tissue levels enough to change anything clinically for someone who is not deficient is a separate question, and a much less settled one. Grade C for most wellness uses: sound mechanism, limited and inconsistent human randomized data, no approved indication.

Fundamentally it donates electrons. It neutralizes reactive oxygen species — hydrogen peroxide, lipid hydroperoxides — by handing over a hydrogen atom and becoming glutathione disulfide in the process. Glutathione reductase then rebuilds it using NADPH, which keeps the cycle turning continuously [1]. It also binds reactive electrophiles in phase II detoxification, making them water-soluble so the kidneys or bile can carry them out.

On pigmentation, the proposal is that it competes with tyrosinase — the enzyme at the heart of melanin production — and pushes synthesis away from darker eumelanin toward lighter pheomelanin. That is the basis of the off-label skin-lightening use. The same antioxidant activity is proposed to blunt UV-driven oxidative damage in skin. Both proposals rest on cell work or small human studies rather than on large randomized trials, which is worth holding in mind given how confidently they are marketed.

Oral absorption was long assumed to be negligible, since intestinal enzymes cleave the tripeptide before it can be taken up. A 2015 randomized controlled trial complicated that assumption: 500 or 1,000 mg a day over six months significantly raised glutathione in red blood cells and lymphocytes against placebo, with the larger dose producing larger rises [2]. Encouraging — and it establishes that blood levels move, not that anything a patient would notice follows.

Skin lightening is the most studied application. A 2019 systematic review found several small placebo-controlled trials where oral dosing between 250 and 1,000 mg a day measurably reduced melanin index across four to twelve weeks [5]. The effects were modest, the trials short, the samples small. A 2021 double-blind randomized trial combining topical and oral forms confirmed lightening against placebo, without any way to separate which route did the work [7]. A 2017 review summarized the antimelanogenic and antioxidant skin findings and acknowledged the same limitations of size and duration [4].

On injected forms, a 2016 critical review laid out the tension directly: the drug being used widely for skin lightening while large-scale randomized evidence stayed scarce and safety concerns accumulated on the record [3]. A 2020 controlled assessor-blinded study of parenteral dosing did find a measurable lightening effect on treated skin, in a very small sample with no long-term follow-up [6].

Grade C overall. The mechanistic foundation is solid, and smaller trials suggest both oral and parenteral routes can raise glutathione and modestly shift skin pigmentation. What does not exist is any large, well-powered trial showing meaningful clinical outcomes — better immune function, lower disease risk, any hard endpoint — in otherwise healthy adults. The dramatic anti-aging, detox and immune-boosting claims sold around this compound run well past what has been demonstrated.

Human trials of oral supplementation have used 250 to 1,000 mg a day, taken at once or split, usually with food. Liposomal versions are marketed on better absorption, and published human comparisons are thin. IV protocols commonly run 600 to 1,200 mg a session, frequently alongside vitamin C, one to three times a week where skin is the target. Intramuscular dosing is smaller, typically 200 to 600 mg a session.

No dose or schedule here has been validated in a large controlled trial, so every recommendation reflects convention among prescribers rather than established evidence — a distinction worth insisting on when someone quotes you a protocol. Work with a licensed provider who can weigh your own health factors and watch for adverse effects.

Taken by mouth at studied doses it appears well tolerated, with bloating and loose stools the usual complaints. Given by IV or intramuscularly it carries the risk of infusion and injection reactions — flushing, itching, and occasionally serious hypersensitivity. Rare but severe events, Stevens-Johnson syndrome and toxic epidermal necrolysis among them, have turned up in connection with IV use for lightening skin, which is why the FDA, Health Canada and regulators in the Philippines and Europe have all issued warnings against injecting it for that purpose.

Compounded injectable glutathione is not an FDA-approved drug, and regulators have said specifically that injectable products marketed for lightening skin are not proven safe or effective for it. Anyone with G6PD deficiency, severe liver disease, or a previous hypersensitivity reaction to it should avoid the injectable forms entirely. Use in pregnancy or while breastfeeding is not advised outside medical supervision.